Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 360

1.

 Schistosomal portal hypertension: Randomized trial comparing endoscopic therapy alone or preceded by esophagogastric devascularization and splenectomy.

Costa Lacet CM, Neto JB, Ribeiro LT, Oliveira FS, Wyszomirska RF, Strauss E.

Ann Hepatol. 2016 Sep-Oct;15(5):738-44. doi: 10.5604/16652681.1212528.

PMID:
27493113
2.

Treatment for cirrhotic ascites.

Kawaratani H, Fukui H, Yoshiji H.

Hepatol Res. 2016 Jul 1. doi: 10.1111/hepr.12769. [Epub ahead of print] Review.

PMID:
27363974
3.

Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?

Uslan I, Olt S, Eminler AT.

Hepatogastroenterology. 2015 Jun;62(140):1023-6.

PMID:
26902049
4.

Population-based epidemiology of primary biliary cirrhosis in South Korea.

Kim KA, Ki M, Choi HY, Kim BH, Jang ES, Jeong SH.

Aliment Pharmacol Ther. 2016 Jan;43(1):154-62. doi: 10.1111/apt.13448. Epub 2015 Nov 2.

PMID:
26526639
5.

All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus.

Xu F, Moorman AC, Tong X, Gordon SC, Rupp LB, Lu M, Teshale EH, Spradling PR, Boscarino JA, Trinacty CM, Schmidt MA, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators; Chronic Hepatitis Cohort Study CHeCS Investigators.

Clin Infect Dis. 2016 Feb 1;62(3):289-97. doi: 10.1093/cid/civ860. Epub 2015 Sep 28.

PMID:
26417034
6.

Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.

Rosenqvist K, Eriksson LG, Rorsman F, Sangfelt P, Nyman R.

Acta Radiol. 2016 May;57(5):572-9. doi: 10.1177/0284185115595060. Epub 2015 Aug 7.

PMID:
26253926
7.

Treatment of Spontaneous Bacterial Peritonitis.

Salerno F, La Mura V.

Dig Dis. 2015;33(4):582-5. doi: 10.1159/000375358. Epub 2015 Jul 6.

PMID:
26159277
8.

Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.

Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A, Lutz H, Schoo R, Lorenzen H, Trebicka J, Appenrodt B, Schepke M, Fimmers R; German Study Group for Prophylaxis of Variceal Rebleeding.

Gastroenterology. 2015 Sep;149(3):660-8.e1. doi: 10.1053/j.gastro.2015.05.011. Epub 2015 May 16.

9.

Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation.

Faitot F, Allard MA, Pittau G, Ciacio O, Adam R, Castaing D, Cunha AS, Pelletier G, Cherqui D, Samuel D, Vibert E.

Hepatology. 2015 Jul;62(1):179-87. doi: 10.1002/hep.27864. Epub 2015 May 20.

PMID:
25914217
10.

Comparison of effects of devascularization versus shunt on patients with portal hypertension: a meta-analysis.

Zong GQ, Fei Y, Liu RM.

Hepatogastroenterology. 2015 Jan-Feb;62(137):144-50. Review.

PMID:
25911885
11.
12.

Presentation and complications associated with cirrhosis of the liver.

Poordad FF.

Curr Med Res Opin. 2015 May;31(5):925-37. doi: 10.1185/03007995.2015.1021905. Review.

PMID:
25697811
13.

Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Siramolpiwat S.

World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996. Review.

14.

Acute kidney injury in schistosomiasis: a retrospective cohort of 60 patients in Brazil.

Duarte DB, Vanderlei LA, de Azevêdo Bispo RK, Pinheiro ME, da Silva Junior GB, De Francesco Daher E.

J Parasitol. 2015 Apr;101(2):244-7. doi: 10.1645/13-361.1. Epub 2014 Nov 13.

PMID:
25393856
15.

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.

Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Summereder C, Hagmann M, Blacky A, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Reiberger T.

PLoS One. 2014 Nov 4;9(11):e110503. doi: 10.1371/journal.pone.0110503. eCollection 2014.

16.

Utility of endoscopic ultrasound in patients with portal hypertension.

Hammoud GM, Ibdah JA.

World J Gastroenterol. 2014 Oct 21;20(39):14230-6. doi: 10.3748/wjg.v20.i39.14230. Review.

17.

Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.

Bettinger D, Knüppel E, Euringer W, Spangenberg HC, Rössle M, Thimme R, Schultheiß M.

Aliment Pharmacol Ther. 2015 Jan;41(1):126-36. doi: 10.1111/apt.12994. Epub 2014 Oct 20.

18.

Comparison of percutaneous transhepatic variceal embolization (PTVE) followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage.

Duan X, Zhang K, Han X, Ren J, Xu M, Huang G, Zhang M.

J Vasc Interv Radiol. 2014 Dec;25(12):1858-65. doi: 10.1016/j.jvir.2014.08.019. Epub 2014 Oct 11.

PMID:
25311969
19.

Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score.

Donadon M, Costa G, Cimino M, Procopio F, Fabbro DD, Palmisano A, Torzilli G.

World J Surg. 2015 Jan;39(1):237-43. doi: 10.1007/s00268-014-2786-6.

PMID:
25217112
20.

Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis.

Ripoll C, Bari K, Garcia-Tsao G.

J Clin Gastroenterol. 2015 Aug;49(7):613-9. doi: 10.1097/MCG.0000000000000207.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk